Cargando…

Favorable glycemic response after pancreatoduodenectomy in both patients with pancreatic cancer and patients with non-pancreatic cancer

Diabetes mellitus (DM) is prevalent in patients with pancreatic cancer and tends to improve after tumor resection. However, the glycemic response of non-pancreatic cancer patients after surgery has not been examined in detail. We aimed to investigate the changes in glucose metabolism in patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sohn, Seo Young, Lee, Eun Kyung, Han, Sung-Sik, Lee, You Jin, Hwangbo, Yul, Kang, Young Hwa, Lee, Seung Duk, Kim, Seong Hoon, Woo, Sang Myung, Lee, Woo Jin, Hong, Eun Kyung, Park, Sang-Jae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393016/ https://www.ncbi.nlm.nih.gov/pubmed/29718860 http://dx.doi.org/10.1097/MD.0000000000010590

Ejemplares similares

Perioperative transfusion in pancreatoduodenectomy: The double-edged sword of pancreatic surgeons
por: Park, Hyeong Min, et al.
Publicado: (2017)

Risk of Pancreatic Cancer in Relation to ABO Blood Group and Hepatitis C Virus Infection in Korea: A Case-Control Study
por: Woo, Sang Myung, et al.
Publicado: (2013)

Neoadjuvant FOLFIRINOX Followed by Pancreatoduodenectomy for Pancreatic Cancer in Patients with Previous Transhiatal Esophagectomy for Esophageal Cancer
por: Kim, Juwan, et al.
Publicado: (2022)

Individualized metabolic profiling stratifies pancreatic and biliary tract cancer: a useful tool for innovative screening programs and predictive strategies in healthcare
por: Lee, Jun Hwa, et al.
Publicado: (2018)

Acute Hyperglycemia Associated with Anti-Cancer Medication
por: Hwangbo, Yul, et al.
Publicado: (2017)

Association between glycemic status and the risk of acute pancreatitis: a nationwide population-based study
por: Cho, In Rae, et al.
Publicado: (2023)

Changes in Dietary Intake, Body Weight, Nutritional Status, and Metabolic Rate in a Pancreatic Cancer Patient
por: Kim, So Young, et al.
Publicado: (2013)

Does Preoperative Acute Pancreatitis Inevitably Delay Pancreatoduodenectomy in Patients with Periampullary Tumors?
por: Yoon, So Jeong, et al.
Publicado: (2021)

Prophylactic octreotide for postoperative pancreatic fistula in patients with pancreatoduodenectomy: Risk-stratified analysis
por: Yoon, So Jeong, et al.
Publicado: (2022)

Effectiveness and Safety of Simultaneous Integrated Boost-Proton Beam Therapy for Localized Pancreatic Cancer
por: Kim, Tae Hyun, et al.
Publicado: (2018)

Effectiveness and feasibility of concurrent chemoradiotherapy using simultaneous integrated boost-intensity modulated radiotherapy with and without induction chemotherapy for locally advanced pancreatic cancer
por: Oh, Eun Sang, et al.
Publicado: (2018)

Comprehensive Cancer Panel Sequencing Defines Genetic Diversity and Changes in the Mutational Characteristics of Pancreatic Cancer Patients Receiving Neoadjuvant Treatment
por: Yoon, Kyong-Ah, et al.
Publicado: (2019)

Overall survival of pancreatic ductal adenocarcinoma is doubled by Aldh7a1 deletion in the KPC mouse
por: Lee, Jae-Seon, et al.
Publicado: (2021)

Efficacy and feasibility of proton beam radiotherapy using the simultaneous integrated boost technique for locally advanced pancreatic cancer
por: Kim, Tae Hyun, et al.
Publicado: (2020)

SUN-417 Long Working Hours Are Associated with Hypothyroidism: A Cross-Sectional Study with Population-Representative Data
por: Lee, Young Ki, et al.
Publicado: (2020)

Risk prediction platform for pancreatic fistula after pancreatoduodenectomy using artificial intelligence
por: Han, In Woong, et al.
Publicado: (2020)

Jejunal varix bleeding with extrahepatic portal vein obstruction after pylorus-preserving pancreatoduodenectomy: report of two cases
por: Lee, Seung Duk, et al.
Publicado: (2012)

Development of Patient-Derived Preclinical Platform for Metastatic Pancreatic Cancer: PDOX and a Subsequent Organoid Model System Using Percutaneous Biopsy Samples
por: Choi, Sun Il, et al.
Publicado: (2019)

Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer
por: Kim, Yeon-Joo, et al.
Publicado: (2013)

External validation of risk prediction platforms for pancreatic fistula after pancreatoduodenectomy using nomograms and artificial intelligence
por: Yoon, So Jeong, et al.
Publicado: (2022)

Induction Chemotherapy with Gemcitabine and Cisplatin Followed by Simultaneous Integrated Boost–Intensity Modulated Radiotherapy with Concurrent Gemcitabine for Locally Advanced Unresectable Pancreatic Cancer: Results from a Feasibility Study
por: Woo, Sang Myung, et al.
Publicado: (2017)

A Case of Primary Pancreatic Non-Hodgkin's Lymphoma
por: Lee, Myung-Kwon, et al.
Publicado: (2006)

The catalytically defective receptor protein tyrosine kinase EphA10 promotes tumorigenesis in pancreatic cancer cells
por: Shin, Won‐Sik, et al.
Publicado: (2020)

Bouveret's syndrome: a case report and a review of the literature
por: Lee, Woohyung, et al.
Publicado: (2012)

Should the Splenic Vein Be Preserved—Fate of Sinistral Portal Hypertension after Pancreatoduodenectomy with Vascular Re-Section for Pancreatic Cancer
por: Kim, Sung Hyun, et al.
Publicado: (2022)

Development and Validation of a Prediction Model to Estimate Individual Risk of Pancreatic Cancer
por: Yu, Ami, et al.
Publicado: (2016)

Seaweed and Iodine Intakes and SLC5A5 rs77277498 in Relation to Thyroid Cancer
por: Hoang, Tung, et al.
Publicado: (2022)

Maintenance of skeletal muscle mass during FOLFIRINOX is a favorable prognostic factor in pancreatic cancer patients
por: Shin, Dong Woo, et al.
Publicado: (2021)

Overexpression of SIRT1 Protects Pancreatic β-Cells Against Cytokine Toxicity by Suppressing the Nuclear Factor-κB Signaling Pathway
por: Lee, Ji-Hyun, et al.
Publicado: (2009)

Genomic Instability of Circulating Tumor DNA as a Prognostic Marker for Pancreatic Cancer Survival: A Prospective Cohort Study
por: Woo, Sang Myung, et al.
Publicado: (2021)

Analysis of MicroRNA Signature Differentially Expressed in Pancreatic Islet Cells Treated with Pancreatic Cancer-Derived Exosomes
por: Kim, Young-gon, et al.
Publicado: (2023)

RRM1 Expression as a Prognostic Biomarker for Unresectable or Recurrent Biliary Tract Cancer Treated with Gemcitabine plus Cisplatin
por: Chun, Jung Won, et al.
Publicado: (2021)

Exploring Connections between Oral Microbiota, Short-Chain Fatty Acids, and Specific Cancer Types: A Study of Oral Cancer, Head and Neck Cancer, Pancreatic Cancer, and Gastric Cancer
por: Nouri, Zahra, et al.
Publicado: (2023)

Pancreatoduodenectomy with portal vein resection favors the survival time of patients with pancreatic ductal adenocarcinoma: A propensity score matching analysis
por: Xie, Zhi-Bo, et al.
Publicado: (2019)

Risk factors deteriorating severe exocrine pancreatic insufficiency measured by stool elastase after pancreatoduodenectomy and the risk factors for weight loss
por: Cho, Ara, et al.
Publicado: (2022)

Postoperative CA19-9 Change Is a Useful Predictor of Intrahepatic Cholangiocarcinoma Survival following Liver Resection
por: Yoo, Tae, et al.
Publicado: (2015)

A case of gallbladder cancer combined with ectopic individual opening of pancreatic and bile ducts to the duodenal bulb
por: Lee, Woohyung, et al.
Publicado: (2015)

Association among Body Mass Index, Genetic Variants of FTO, and Thyroid Cancer Risk: A Hospital-Based Case-Control Study of the Cancer Screenee Cohort in Korea
por: Hoang, Tung, et al.
Publicado: (2021)

Pancreatic cancer induces muscle wasting by promoting the release of pancreatic adenocarcinoma upregulated factor
por: Yoo, Wonbeak, et al.
Publicado: (2021)

Pancreaticoduodenectomy of Pancreatic Ductal Adenocarcinoma in the Elderly
por: Kang, Chang Moo, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_b1q1kubvsntn59i2qg5kd72gnd